Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2014-03-05 16:26:21

NEWARK, Calif., March 05, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the 26th Annual ROTH Conference on Monday, March 10, 2014, at the Ritz Carlton in Dana Point, California. Depomed management is scheduled to present at 1:00 p.m. PT on Monday, March 10, with one-on-one meetings held throughout the day. A webcast of the presentation can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A...

2014-03-04 23:26:00

DeepResearchReports.com adds “2014 Deep Research Report on Global and China Salicylic Acid (SA) Industry” and “2014 Deep Research Report on Global and China Hyaluronic Acid Solution Industry” reports to its research database. Dallas, Texas (PRWEB) March 04, 2014 "2014 Deep Research Report on Global and China Hyaluronic Acid Solution Industry” is a professional and in-depth research report on China and Global Hyaluronic Acid Solution market. The report introduces Hyaluronic...

2014-02-21 08:22:21

DUBLIN, Feb. 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/q27vfh/ophthalmic_drugs ) has announced the addition of the "Ophthalmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Globally, the ophthalmic drugs market is witnessing significant growth due to increasing prevalence of eye disorders such as diabetic...

2014-02-20 16:24:56

NEWARK, Calif., Feb. 20, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the 2014 RBC Capital Markets' Healthcare Conference at The New York Palace Hotel in New York City. The presentation at the RBC conference is scheduled for 2:05 pm EST (11:05 am PST) on Wednesday, February 26, 2014. Depomed will also be presenting at the Cowen 34(th) Annual Healthcare Conference at the Boston Marriott Copley Place Hotel in Boston at 8:40 am EST...

2014-02-12 08:29:39

Vireo's latest marketing efforts emphasize its commitment to educating consumers who are seeking an alternative to Ibuprofen and NSAIDs MADISON, Tenn., Feb. 12, 2014 /PRNewswire/ -- Vireo Systems has recently completed a major packaging and design initiative for its flagship product, AminoActiv ® (http://aminoactiv.com) the #1 alternative to Ibuprofen and NSAIDs. New product labeling and packaging formats are intended to raise AminoActiv's visibility to consumers searching for...

2014-02-11 16:26:04

WHIPPANY, N.J., Feb. 11, 2014 /PRNewswire/ -- Bayer HealthCare today issued the following press statement from Dr. Irene Laurora, Vice President, US Medical Affairs, following a joint meeting of the Arthritis Advisory Committee (AAC) and Drug Safety Committee and Risk Management Advisory Committee (DSaRM) on February 10-11, 2014. The joint Advisory Committee panel reviewed the data and analyses published since the last non-steroidal anti-inflammatory drug (NSAID) panel review in 2005...

2014-02-11 16:22:23

DUBLIN, February 11, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/v8t3kj/salicylic_acid) has announced the addition of the "Concise Analysis of the International Salicylic Acid Market - Forecast to 2019" [http://www.researchandmarkets.com/research/v8t3kj/salicylic_acid ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Salicylic acid is a beta hydroxyl acid, found naturally in...

2014-02-10 08:26:43

MISSISSAUGA, ON, Feb. 10, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products today announced the U.S. commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%) by its U.S. commercial licensee Mallinckrodt (NYSE:MNK). PENNSAID 2% is the first twice per day topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the United States for the...

2014-02-03 23:02:55

Transparency Market Research Report Added "Ophthalmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018" to its database. Browse Full Report: http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html. Albany, New York (PRWEB) February 03, 2014 According to a new market report published by Transparency Market Research "Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal...

2014-01-24 08:23:33

NEW YORK, January 24, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018," the global ophthalmic drugs market was valued at USD 16 billion in 2012 and is expected to grow at a CAGR of 5.2% from 2013 to 2018, to reach an estimated value of USD 21.6...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related